Marcus Corporation Appoints Paul A. Leff to Board of Directors
ByAinvest
Tuesday, Aug 5, 2025 10:23 am ET1min read
COR--
Donato's appointment follows Mallinckrodt's merger with Endo, Inc., creating a global, diversified therapeutics leader. The new board now consists of four members from each legacy company. Donato, who was jointly selected by her fellow board members, will bring her wealth of experience to inform strategic discussions and guide Mallinckrodt's future direction. Board Chair Paul Efron expressed delight in welcoming Donato, noting her significant contributions to the healthcare industry [1].
Donato's career spans over three decades, including stints at Bayer Healthcare Pharmaceuticals and McKinsey & Company. She currently serves on the boards of Virtua Health System and COPILOT. Her academic background includes a Bachelor of Arts in Economics and Public Policy from Swarthmore College and an MBA in Finance and Healthcare Management from The Wharton School [1].
References:
[1] Mallinckrodt plc. (2025, August 4). Mallinckrodt names Leslie Donato to board of directors. PRNewswire. Retrieved from https://www.biospace.com/press-releases/mallinckrodt-names-leslie-donato-to-board-of-directors
MCS--
Paul A. Leff has been elected to the Marcus Corporation Board of Directors. Leff is the founder of Warbasse67 and co-founder of Perry Capital, a hedge fund firm. He has also been a limited partner of the Las Vegas Raiders since 2007. Leff's experience in financial management and strategic planning is expected to benefit Marcus Corporation's growth opportunities.
Mallinckrodt plc announced the appointment of Leslie Donato to its Board of Directors, completing a nine-member board. Donato, an accomplished healthcare executive, brings extensive experience in strategy, corporate development, marketing, commercialization, and product development. She most recently served as Executive Vice President and Chief Strategy Officer at Cencora, Inc., where she executed an ambitious M&A and growth strategy that contributed to a 130% increase in the company's market capitalization over five years [1].Donato's appointment follows Mallinckrodt's merger with Endo, Inc., creating a global, diversified therapeutics leader. The new board now consists of four members from each legacy company. Donato, who was jointly selected by her fellow board members, will bring her wealth of experience to inform strategic discussions and guide Mallinckrodt's future direction. Board Chair Paul Efron expressed delight in welcoming Donato, noting her significant contributions to the healthcare industry [1].
Donato's career spans over three decades, including stints at Bayer Healthcare Pharmaceuticals and McKinsey & Company. She currently serves on the boards of Virtua Health System and COPILOT. Her academic background includes a Bachelor of Arts in Economics and Public Policy from Swarthmore College and an MBA in Finance and Healthcare Management from The Wharton School [1].
References:
[1] Mallinckrodt plc. (2025, August 4). Mallinckrodt names Leslie Donato to board of directors. PRNewswire. Retrieved from https://www.biospace.com/press-releases/mallinckrodt-names-leslie-donato-to-board-of-directors
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet